Status
Conditions
Treatments
About
Aromatherapy, visual and auditory stimuli are used together in the Snoezelen room. Aromatherapy increases the production of endorphins, reduces the intensity of pain and distracts the attention from the pain. Music also blocks the transmission of nerve impulses to the spinal cord.Considering these effects, the study emerges as a new technology for the midwifery field in our country. Although the use of snoezelen rooms in the delivery environment is becoming increasingly widespread abroad, it has not been used in delivery services in any hospital in our country. The primary purpose of this study is to convert a room in the delivery room of the hospital into a Snoezelen room and have women complete their delivery process in this room, and the secondary purpose is to determine the effect of the Snoezelen room on the delivery process.
The primiparous pregnant women selected for the intervention and control groups will be informed about the purpose of the study and the applications by the research midwife or gynecologist following the birth and will be administered the "Pregnant Information Form", "Visual Analog Scale (VAS)", "Fear of Childbirth Scale", "Birth Comfort Scale", and after birth, the "Birth Information Form", "Birth Satisfaction Scale". The Beta Endorphin Level Recording Form will be filled out.
Full description
This study is a randomized controlled trial to evaluate the effect of the snoezelen room on the delivery process. This clinical trial will be registered on ClinicalTrials.gov. Reporting will be carried out in accordance with CONSORT for parallel group randomized studies. (CONSORT 2010, Access date: June 10, 2023). The study is planned to be conducted in the delivery room of Sakarya Education and Research Hospital, Gynecology and Pediatrics Service Building between October 2023 and July 2024. The reason for choosing this hospital for the study is that it is the only hospital in Sakarya with a fully equipped Gynecology and Obstetrics unit for delivery.
Intervention Group Implementation Steps The primiparous pregnant women selected for the intervention group will be informed about the purpose of the study and the applications by the researcher midwife or gynecologist following the birth and if they accept to participate in the study voluntarily, their written consent will be obtained, then they will be taken to the Snoezelen delivery room and the researcher will observe during this process. First, the "Pregnant Information Form" will be used, and the "Visual Analog Scale (VAS)" will be used to describe the pain of the pregnant woman during labor. In addition, the "VAS" will be asked and filled in every hour and the average pain level during labor will be determined. The "Fear of Childbirth Scale" will be applied when the cervical dilation of the pregnant woman is 3 cm and above, the "Birth Comfort Scale" will be applied when the cervical dilation is 8 cm, the "Birth Information Form" will be applied after birth, and the "Birth Satisfaction Scale" will be applied two hours after birth. In order to determine beta-endorphin levels; when the cervical dilation is 3 cm. and 10 cm. Intravenous blood samples will be taken 3 times, one during pregnancy and one after the birth of the placenta. The Beta Endorphin Level Record Form will be filled out.
Control Group Application Steps Primiparous pregnant women selected for the control group will be taken to the standard delivery room after being informed about the purpose of the study and the practices, and if they voluntarily agree to participate in the study, their written consent will be obtained, and routine practices in the hospital will not be deviated from. In order to ensure that there is no difference between the groups in terms of episiotomy and delivery techniques, women who are followed and delivered by the same midwife will be included in the study. The same forms will be used in the intervention group.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
104 participants in 2 patient groups
Loading...
Central trial contact
Melek Balçık Çolak, RM, PhD, Asst. Prof.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal